First human test of experimental cancer therapy begins
Disease control
Ongoing
This early-stage study is testing a new drug called AXN-2510 in adults with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find the safest dose, understand side effects, and see how long the drug stays in the body. Participants re…
Phase: PHASE1 • Sponsor: Axion Bio, Inc • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC